Patent · US Expired

Anti-tumor antibody compositions and methods of use

US6824780B1 · kind B1 · utility

154Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2000
Grant dateNov 30, 2004
Priority date
Expiry dateOct 27, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides antibodies targeted at a tumor antigen prevalent on prostate tumors and methods useful in alleviating cancers expressing the antigen, as well as nucleic acids and cells for expressing the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.